Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 7/20 | 0.38 |
| ▸ | CSNK1E | P49674 | 7/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.37 |
| ▸ | CKS1B | P61024 | 2/20 | 0.35 |
| ▸ | SKP1 | P63208 | 2/20 | 0.35 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26645317 | 1.00 | CSNK1D (0.38) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| Hydrochloric Acid SCHEMBL26645457 | 0.94 | CSNK1D (0.41) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645301 | 0.85 | CSNK1D (0.44) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645705 | 0.84 | CSNK1D (0.46) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645681 | 0.81 | CSNK1E (0.48) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645250 | 0.80 | CSNK1D (0.48) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL30623021 | 0.80 | CSNK1E (0.44) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645466 | 0.80 | CSNK1D (0.49) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL26645522 | 0.80 | CSNK1E (0.44) | CSNK1DCSNK1EGPR119CKS1BSKP1 | |
| SCHEMBL30622919 | 0.79 | CSNK1E (0.46) | CSNK1DCSNK1EGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |